Aligos Therapeutics Inc.
ALGS | NASDAQ
$5.95
+$0.46 (+8.38%)
Sep 22, 2026, 12:08 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 31.52M | 4.71M | 2.19M | 2.65M | 3.17M | 3.27M | 3.95M | 6M | 7.97M | 13.79M | 15.53M | 16.39M | 17.25M | 14.06M | 13.91M | 10.74M | 8.17M | 6.02M | 4.36M | 3.99M | 2.46M | 910K |
Cost of Revenue | 257K | 516K | 516K | 259K | 259K | 610K | 610K | 610K | 610K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 31.26M | 4.19M | 1.67M | 2.39M | 2.92M | 2.66M | 3.34M | 5.39M | 7.36M | 13.79M | 15.53M | 16.39M | 17.25M | 14.06M | 13.91M | 10.74M | 8.17M | 6.02M | 4.36M | 3.99M | 2.46M | 910K |
Operating Income | -78.99M | -95.67M | -87.99M | -86.73M | -78.5M | -86.35M | -89.15M | -94.59M | -93.53M | -86.26M | -88.13M | -84.81M | -84.69M | -85.94M | -97.58M | -112.85M | -126.97M | -136.14M | -128.32M | -124.66M | -113.15M | -104.85M |
Interest Income | 1.96M | 2.13M | 2.16M | 1.93M | 2.01M | 1.93M | 1.67M | 2.95M | 3.49M | 4.13M | 4.3M | 3.58M | 3.05M | 2.3M | 1.64M | 809K | 363K | 223K | 242K | 197K | 411K | 713K |
Pretax Income | -72.75M | -89.73M | -23.88M | -86.15M | -73.84M | -52.91M | -130.88M | -76.68M | -75.52M | -98.81M | -86.88M | -80.8M | -81.45M | -83.29M | -95.94M | -111.88M | -126.21M | -136.12M | -128.19M | -124.62M | -124.92M | -115.98M |
Net Income | -75.96M | -90.32M | -24.19M | -86.46M | -74.18M | -53.26M | -131.21M | -76.95M | -75.74M | -99.59M | -87.68M | -81.67M | -82.25M | -83.39M | -96.05M | -111.87M | -126.38M | -136.27M | -128.33M | -125.04M | -125.21M | -116.19M |
Selling & General & Admin | 21.88M | 21.82M | 20.46M | 20.93M | 20.4M | 20.61M | 22.22M | 23.48M | 25.3M | 28.78M | 30.62M | 31.31M | 30.13M | 28.46M | 26.41M | 29.01M | 30.22M | 29.2M | 28.53M | 25.02M | 22.77M | 20.31M |
Research & Development | 88.38M | 78.3M | 69.45M | 68.45M | 61.28M | 68.41M | 70.27M | 76.5M | 75.59M | 71.27M | 73.04M | 69.88M | 71.81M | 71.54M | 85.08M | 94.58M | 104.92M | 112.96M | 104.15M | 103.64M | 92.84M | 85.46M |
Other Expenses | n/a | -259K | -259K | -259K | -259K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 110.26M | 99.86M | 89.66M | 89.12M | 81.42M | 89.01M | 92.49M | 99.98M | 100.89M | 100.05M | 103.66M | 101.2M | 101.94M | 100M | 111.49M | 123.58M | 135.13M | 142.16M | 132.68M | 128.65M | 115.6M | 105.76M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -610K | -610K | -610K | -610K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 110.51M | 100.38M | 90.17M | 89.38M | 81.68M | 89.62M | 93.1M | 100.59M | 101.5M | 100.05M | 103.66M | 101.2M | 101.94M | 100M | 111.49M | 123.58M | 135.13M | 142.16M | 132.68M | 128.65M | 115.6M | 105.76M |
Income Tax Expense | 3.21M | 588K | 314K | 311K | 346K | 350K | 331K | 274K | 212K | 780K | 795K | 874K | 802K | 92K | 106K | -1K | 168K | 149K | 141K | 418K | 292K | 205K |
Shares Outstanding (Basic) | 10.43M | 10.4M | 10.38M | 10.37M | 10.35M | 8.41M | 6.28M | 6.27M | 6.26M | 15.57M | 24.87M | 43.5M | 43.22M | 42.91M | 42.84M | 42.76M | 42.67M | 42.51M | 42.34M | 42.4M | 37.62M | 37.43M |
Shares Outstanding (Diluted) | 10.43M | 10.4M | 10.38M | 10.37M | 10.35M | 8.71M | 6.28M | 6.27M | 6.27M | 15.57M | 24.87M | 43.5M | 43.22M | 42.91M | 42.84M | 42.76M | 42.67M | 42.51M | 42.34M | 42.4M | 37.62M | 37.43M |
EPS (Basic) | -7.30 | -8.69 | -1.36 | -12.53 | -12.56 | -10.22 | -17.58 | -5.62 | -2.96 | -4.20 | -2.49 | -1.88 | -1.91 | -1.95 | -2.26 | -2.64 | -2.98 | -3.30 | -3.20 | -3.40 | -3.52 | -3.68 |
EPS (Diluted) | -7.30 | -8.69 | -1.53 | -12.70 | -12.73 | -10.39 | -17.58 | -5.62 | -2.96 | -4.20 | -2.49 | -1.88 | -1.91 | -1.95 | -2.26 | -2.64 | -2.98 | -3.30 | -3.20 | -3.40 | -3.52 | -3.68 |
EBITDA | -71.19M | -88.17M | -22.16M | -84.01M | -71.73M | -50.45M | -128.26M | -73.95M | -72.78M | -95.91M | -83.82M | -77.61M | -78.04M | -79.76M | -92.27M | -108.08M | -122.36M | -132.23M | -124.52M | -121.17M | -109.81M | -101.12M |
EBIT | -72.75M | -89.73M | -23.88M | -86.15M | -73.84M | -52.91M | -130.88M | -76.68M | -75.52M | -98.81M | -86.88M | -80.8M | -81.45M | -83.29M | -95.94M | -111.88M | -126.21M | -136.12M | -128.3M | -124.81M | -113.37M | -104.85M |
Depreciation & Amortization | 1.56M | 1.56M | 1.72M | 2.14M | 2.11M | 2.46M | 2.62M | 2.73M | 2.74M | 2.9M | 3.07M | 3.19M | 3.42M | 3.54M | 3.68M | 3.79M | 3.85M | 3.89M | 3.78M | 3.65M | 3.57M | 3.74M |
Add to Watchlist
Select watchlists to add or remove ALGS